Elm Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-5,406
| Closed | -$825K | – | 66 |
|
|
2021
Q4 | $825K | Hold |
5,406
| – | – | 0.46% | 41 |
|
|
2021
Q3 | $874K | Hold |
5,406
| – | – | 0.52% | 34 |
|
|
2021
Q2 | $885K | Hold |
5,406
| – | – | 0.52% | 36 |
|
|
2021
Q1 | $814K | Hold |
5,406
| – | – | 0.51% | 38 |
|
|
2020
Q4 | $819K | Hold |
5,406
| – | – | 0.5% | 33 |
|
|
2020
Q3 | $732K | Sell |
5,406
-70
| -1% | -$9.5K | 0.5% | 40 |
|
|
2020
Q2 | $749K | Sell |
5,476
-150
| -3% | -$19.1K | 0.53% | 37 |
|
|
2020
Q1 | $606K | Hold |
5,626
| – | – | 0.5% | 41 |
|
|
2019
Q4 | $678K | Hold |
5,626
| – | – | 0.43% | 46 |
|
|
2019
Q3 | $560K | Hold |
5,626
| – | – | 0.38% | 48 |
|
|
2019
Q2 | $614K | Hold |
5,626
| – | – | 0.42% | 47 |
|
|
2019
Q1 | $629K | Hold |
5,626
| – | – | 0.44% | 44 |
|
|
2018
Q4 | $543K | Hold |
5,626
| – | – | 0.44% | 45 |
|
|
2018
Q3 | $686K | Hold |
5,626
| – | – | 0.46% | 38 |
|
|
2018
Q2 | $618K | Hold |
5,626
| – | – | 0.47% | 36 |
|
|
2018
Q1 | $601K | Sell |
5,626
-50
| -0.9% | -$5.54K | 0.46% | 35 |
|
|
2017
Q4 | $606K | Hold |
5,676
| – | – | 0.45% | 37 |
|
|
2017
Q3 | $631K | Sell |
5,676
-300
| -5% | -$32.1K | 0.5% | 36 |
|
|
2017
Q2 | $618K | Hold |
5,976
| – | – | 0.51% | 34 |
|
|
2017
Q1 | $584K | Hold |
5,976
| – | – | 0.49% | 39 |
|
|
2016
Q4 | $529K | Hold |
5,976
| – | – | 0.48% | 39 |
|
|
2016
Q3 | $577K | Hold |
5,976
| – | – | 0.53% | 37 |
|
|
2016
Q2 | $513K | Sell |
5,976
-75
| -1% | -$6.73K | 0.49% | 41 |
|
|
2016
Q1 | $526K | Hold |
6,051
| – | – | 0.51% | 39 |
|
|
2015
Q4 | $682K | Sell |
6,051
-24
| -0.4% | -$2.6K | 0.67% | 25 |
|
|
2015
Q3 | $614K | Hold |
6,075
| – | – | 0.64% | 27 |
|
|
2015
Q2 | $747K | Sell |
6,075
-165
| -3% | -$19.8K | 0.7% | 24 |
|
|
2015
Q1 | $714K | Hold |
6,240
| – | – | 0.66% | 25 |
|
|
2014
Q4 | $631K | Sell |
6,240
-75
| -1% | -$7.29K | 0.58% | 30 |
|
|
2014
Q3 | $576K | Hold |
6,315
| – | – | 0.55% | 32 |
|
|
2014
Q2 | $541K | Hold |
6,315
| – | – | 0.5% | 34 |
|
|
2014
Q1 | $498K | Hold |
6,315
| – | – | 0.48% | 39 |
|
|
2013
Q4 | $478K | Buy |
+6,315
| New | +$448K | 0.46% | 43 |
|
Other funds holding IBB
Elm Advisors's IBB Position: Q1 2022 in Review
Elm Advisors sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 5,406 shares — an estimated $825K sold.
Elm Advisors first reported a position in IBB in Q4 2013 and held it in 33 quarters. The position peaked at $885K in Q2 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.
- Elm Advisors reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
- Elm Advisors sold 5,406 iShares Biotechnology ETF shares in Q1 2022, an estimated $825K.
- Elm Advisors first reported a position in iShares Biotechnology ETF in Q4 2013 and held it in 33 quarters.
- Elm Advisors's iShares Biotechnology ETF position peaked at $885K in Q2 2021.
- 897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.
Based on Elm Advisors's 13F filing for Q1 2022, filed 1 Apr 2022.